AKT1 and Alzheimer disease: Taken together, targeting the PI3K-Akt-mTOR pathway and associated pathways via interventions such as Actinidia argute, RGE, rapamycin, 4-aminoquinoline, dupilumab, and phototherapy are some of the available options that have been explored in the management of AD.